| Patents for C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704) |
|---|
| 10/25/2007 | US20070249617 3-(6-p-Tolyl-pyridin-3-yloxy)-1-aza-bicyclo[2.2.2]octane; treatment of psychotic disorders such as schizophrenia, mania, depression and anxiety; neurodegenerataive disorders such as senile dementia, Alzhelmer's disease and other intellectual impairment disorders |
| 10/25/2007 | CA2644979A1 2-(cyclic amino)-pyrimidone derivatives as tpk1 inhibitors |
| 10/24/2007 | CN101061117A Novel naphthyl substituted azabicyclo derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 10/18/2007 | US20070244197 Bactericide against gramnegative bacteria; respiratory system disorders |
| 10/18/2007 | US20070244109 1-{3-[(6-amino-5-nitropyridin-2-yl)amino]propyl}-4-(2,4-dichlorophenyl)-N-[(1S)-2-hydroxy-1-methylethyl]-1H-pyrrole-3-carboxamide; Antidiabetic, hypotensive, antiischemic, anticarcinogenic agents; Alzheimer*s disease, obesity, polycystic ovary syndrome; brain, neurodegenerative and autoimmune diseases |
| 10/17/2007 | EP1742909A4 Anionic-sweetener-based ionic liquids and methods of use thereof |
| 10/17/2007 | CN101056634A Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists |
| 10/17/2007 | CN101054375A Compound capable of inhibiting tubercle bacillus growth and application thereof |
| 10/16/2007 | US7282588 Azaindole inhibitors of aurora kinases |
| 10/16/2007 | US7282509 Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
| 10/11/2007 | US20070238729 Dna-pk inhibitors |
| 10/10/2007 | EP1638677A4 Catalytic asymmetric desymmetrization of prochiral and meso cyclic anhydrides |
| 10/10/2007 | EP1558252B1 Substituted furo [2,3-b]pyridine derivatives |
| 10/10/2007 | CN100341874C Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof |
| 10/04/2007 | WO2007110637A1 Method for extracting target alkaloid using an ionic liquid as extracting solvent |
| 10/03/2007 | EP1448530B1 Heteroaryl carboxylic acid amides |
| 10/02/2007 | US7276608 3-(amino)sulfonylamino-substituted, e.g., N-(1,6-Dibenzyl-2-oxo-1,2,3,4-tetrahydroquinolin-3-yl)-benzenesulfonamide and N-(1-Benzyl-2-oxo-6-(thiophen-3-yl)-1,2,3,4-tetrahydroquinolin-3-yl)benzenesulfonamide; eating, metabolic, obesity, cognitive, neurological, pain, inflammatory and psychiatric disorders |
| 09/27/2007 | US20070225372 Amides as Bace Inhibitors |
| 09/20/2007 | WO2007105049A1 Dibenzyl amine derivatives as cetp inhibitors |
| 09/20/2007 | WO2007089768A3 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them |
| 09/19/2007 | CN101039941A Aminopiperidine derivatives, preparation thereof and therapeutic use thereof |
| 09/18/2007 | US7271176 heterocylic amines such as 2-(5-{3-[4-(4-Chloro-2-methyl-phenyl)-piperazin-1-yl]-propylidene}-5,11-dihydro-10-oxa-1-aza-dibenzo[a,d]cyclohepten-7-yl)-propan-2-ol, used for treating diseases associated with aberrant leukocyte recruitment and/or activation |
| 09/13/2007 | US20070213347 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction |
| 09/13/2007 | US20070213342 2-1-Aza-bicyclo[2.2.2]oct-3-yl-6-phenyl-2,3-dihydro-isoindol-1-one, salts and radioactive materials for drug screening; anxiolytic agents; antidepressants; schizophrenia; cognitive activators; attention disorders; Alzheimer's disease; Parkinson's disease; Tourette's syndrome; neuroprotants; analgesics |
| 09/13/2007 | US20070213331 Beta -secretase (BACE); Alzheimer's disease; 2-(R)-[2-(S)-Amino-3-(3,5-difluorophenyl)-1-(S)-hydroxypropyl]-pyrrolidine-1-carboxylic acid tert-butyl ester |
| 09/13/2007 | US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/12/2007 | EP1831213A1 Novel naphthyl substituted azabicyclo derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 09/12/2007 | EP1831212A1 Nicotinic acetycholine receptor ligands |
| 09/11/2007 | US7268134 Medical devices employing triazine compounds and compositions thereof |
| 09/07/2007 | WO2007100851A1 Therapeutic compounds |
| 09/07/2007 | CA2644068A1 Therapeutic compounds |
| 09/06/2007 | US20070208176 Biphenyl derivatives |
| 09/05/2007 | EP1828179A2 Nicotinic alpha-7 receptor ligands and preparation and uses thereof |
| 09/05/2007 | EP1828112A1 Amine salts of (-)-2-((2-(4-hydroxyphenyl)ethyl)thio)-3-(4-(2-(4-((methylsulfonyl)oxy)phenoxy)ethyl)phenyl)propanoic acid |
| 09/05/2007 | EP1689698A4 Bis-cationic compounds and use thereof |
| 09/05/2007 | CN101029049A Use of recovered and reutilized quinine derivative derivative ligand in synthesizing paclitaxel and polyene paclitaxel sided chain |
| 09/04/2007 | US7265114 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis |
| 08/30/2007 | WO2007097276A1 Pyrrole derivative or salt thereof |
| 08/30/2007 | WO2007097197A1 Amide derivative or salt thereof |
| 08/30/2007 | US20070203175 Productioin of dolasetron |
| 08/30/2007 | US20070203117 modulators of nicotinic and/or of monoamine receptors; as diagnostic tools or monitoring agents; for in vivo neuroimaging in labeled/unlabelled forms; inflammation, pain, neurodegenerative disorders; cholinergic ligands;5-(4-Benzoylamino-phenyl)-furan-2-carboxylic acid(1-aza-bicyclo[2.2.2]oct-3-yl)-amide |
| 08/30/2007 | US20070203115 Novel quaternary ammonium compounds |
| 08/30/2007 | CA2642619A1 Pyrrole derivative or salt thereof |
| 08/30/2007 | CA2642610A1 Amide derivative or salt thereof |
| 08/29/2007 | EP1824848A1 Fused bicycloheterocycle substituted quinuclidine derivatives |
| 08/29/2007 | EP1725538B1 Pyridazinone ureas as antagonists of a4 integrins |
| 08/29/2007 | CN101027300A Novel azabicyclic aryl derivatives and their medical use |
| 08/23/2007 | WO2007093602A1 Enantiopure quinuclidinyloxy pyridazines and their use as nicotinic acetylcholine receptor ligands |
| 08/23/2007 | WO2007093366A1 Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| 08/23/2007 | CA2636617A1 Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| 08/22/2007 | EP1819342A1 Quinoline tachykinin receptor antagonists |
| 08/22/2007 | EP1527073B1 Benzothiophene urea, benzofurane urea, and indole urea, and use of the same as alpha-7 achr agonists |
| 08/16/2007 | US20070191422 Nicotinic acetylcholine receptor ligands |
| 08/16/2007 | US20070191364 Aminopiperidine derivatives, preparation thereof and therapeutic use thereof |
| 08/16/2007 | US20070191345 3-((Hetero)arylsulfonyl)-8-'(aminoalkyl)oxyquinolines as 5-ht6 receptor antagonists for the treatment of cns disorders |
| 08/16/2007 | US20070190041 Novel benzothiazepine and bensothiepine compounds |
| 08/15/2007 | CN101018787A Ligands for G-protein coupled receptors |
| 08/15/2007 | CN101018786A Process for preparing quinuclidinium carbamate derivatives |
| 08/14/2007 | US7256288 For therapy or prophylaxis of diseases and for improving perception, concentration, learning and/or memory |
| 08/09/2007 | US20070185329 Method for producing solifenacin or salts thereof |
| 08/09/2007 | US20070185155 1-(2-{[(3-fluorophenyl)methyl]oxy}ethyl)-4-[hydroxy(diphenyl)methyl]-1-azoniabicyclo[2.2.2]octane bromide; muscle relaxants, respiratory system disorders; asthma, bronchitis, chronic obstructive lung disease, chronic bronchitis, chronic respiratory obstruction, pulmonary fibrosis, pulmonary fibrosis |
| 08/09/2007 | US20070185086 Pharmaceutical Compositions and Methods for Effecting Dopamine Release |
| 08/09/2007 | CA2640398A1 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them |
| 08/08/2007 | CN101012226A Method of synthesizing 3-quininone hydrochlorate |
| 08/08/2007 | CN101012200A Process for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases |
| 08/07/2007 | US7253283 9-[4-[4-[[2-(2,2,2-trifluoroethoxy)benzoyl]amino]-1-piperidinyl]butyl]-N-(2,2,2-trifluoroethyl)-9H-fluorene-9-carboxamide; non-steroidal modulator of the glucocorticoid receptor, AP-1, and/or NF- kappa B activity, obesity, diabetes, inflammatory and immune diseases |
| 08/01/2007 | EP1811999A1 Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists |
| 08/01/2007 | EP1289929B1 Shortened synthesis of 3,3-diarylpropylamine derivatives |
| 08/01/2007 | CN1329382C Novel arylsusfonamide compounds for treatment of obesity, type II diabetes and CNS-disorders |
| 07/31/2007 | USRE39754 Benzamide derivatives and pharmaceutical compositions containing same |
| 07/31/2007 | US7250443 Pyrrole based inhibitors of glycogen synthase kinase 3 |
| 07/26/2007 | WO2007066088A3 Process for preparing a coupling product by using alpha-lithio-quinuclidine n-oxide |
| 07/26/2007 | US20070173646 e.g. 4-[cyano(di-2-thienyl)methyl]-1-[3-(phenyloxy)propyl]-1-azoniabicyclo[2.2.2]octane bromide; muscle relaxants, respiratory system disorders; asthma, emphysema, bronchitis, chronic obstructive lung disease, chronic bronchitis, chronic respiratory obstruction, pulmonary fibrosis, pulmonary fibrosis |
| 07/26/2007 | US20070173528 Process for preparing solifenacin |
| 07/25/2007 | EP1355873B1 Pleuromutilin derivatives with antimicrobial activity |
| 07/24/2007 | US7247728 Bicyclic N-arylamides |
| 07/18/2007 | CN101001856A Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof |
| 07/12/2007 | US20070161633 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
| 07/11/2007 | EP1497287A4 Quinolinone derivatives |
| 07/11/2007 | CN1325501C Heterocyclic compounds |
| 07/11/2007 | CN1325493C Aza-bicycloalkyl ethers and their use as alpha7-nachr agonist |
| 07/10/2007 | US7241787 Substituted N-cycloexylimidazolinones, process for their preparation and their use as medicaments |
| 07/10/2007 | US7241773 E.g., 3-(3-Phenoxyphenoxy)quinuclidine and 2-(1-aza-bicyclo[2.2.2]oct-3-yloxy)-6H, 12H-5, 11-methano-dibenzo[b,f][1,5]diazocine; treating conditions or disorders prevented by or ameliorated by nicotinic acetylcholine receptors ligands such as Alzheimer's and schizophrenia |
| 07/05/2007 | WO2007076116A2 Intermediates for preparing solifenacin |
| 07/05/2007 | US20070155725 N-(1-Aza-bicyclo[2.2.2]oct-3-yl)-5-cyano-2-(3,5-dichloro-phenoxy)-benzenesulfonamide; asthma, allergic rhinitis or lung granuloma, HIV; CC type chemokine receptor antagonist |
| 07/05/2007 | CA2634999A1 Muscarinic agonists and methods of use thereof |
| 07/05/2007 | CA2630846A1 Intermediates for preparing solifenacin |
| 07/04/2007 | EP1802616A1 Novel azabicyclic aryl derivatives and their medical use |
| 07/04/2007 | EP1375496B1 N-aryl-substituted cyclic amine derivative and medicine containing the same as active ingredient |
| 07/03/2007 | US7238709 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence |
| 07/03/2007 | US7238692 Stent or a drug delivery or elution device with a disposed traiazine compound such as 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4-diamine for inhibiting smooth muscle proliferation; restenosis and atherosclerosis |
| 06/28/2007 | US20070149563 N-(1-Azabicyclo[2.2.2]oct-3-yl)(2-(3-pyridyl)thiazole-4-carboxamide); nicotinic acetylcholine receptor ligands; psychotic and intellectual impairment disorders; antidepressant, anxiolytic agent; Alzheimer's disease, cognitive or attention disorders |
| 06/28/2007 | US20070149562 Oxopiperidine derivatives, preparation and therapeutic use thereof |
| 06/21/2007 | US20070142428 isoquinoline-3-carboxylic acid{(S)-1-azabicyclo[2.2.2]oct-3-yl}-amide; alpha 7 nicotinic acetylcholine receptor agonists; psychotic disorders such as schizophrenia, mania, depression and anxiety; neurodegenerative disorders such as senile dementia, Alzheimer's disease; attention deficit disorders |
| 06/21/2007 | US20070142370 Azabicyclooctan-3-one derivatives and use thereof |
| 06/20/2007 | CN1984911A 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha7-NACHR ligands for the treatment of CNS diseases |
| 06/14/2007 | WO2007067629A1 Bradykinin 1 receptor antagonists |
| 06/14/2007 | US20070135641 Synthesis |
| 06/14/2007 | US20070135375 Sulfamoyl sulfonate prodrugs |
| 06/14/2007 | US20070134729 Novel antibacterial agents |